Related Experiment Video
Updated: Jul 11, 2026

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a
J M Saland1, S H Emre, B L Shneider
1Department of Pediatrics, The Mount Sinai Medical Center, New York, USA. jeff.saland@mssm.edu
Insights
A child with atypical hemolytic uremic syndrome (HUS) due to complement factor H mutations underwent a combined liver-kidney transplant. This successful procedure offered a favorable long-term outcome, overcoming previous transplant failures.
Area of Science:
- Nephrology
- Transplantation Immunology
- Genetics
Background:
- Atypical hemolytic uremic syndrome (HUS) is a severe thrombotic microangiopathy often linked to genetic complement system dysregulation.
- Complement factor H (CFH) mutations are a significant cause of HUS, leading to renal failure and transplant complications.
Observation:
- A pediatric patient with CFH mutations experienced rapid progression to end-stage renal disease (ESRD) and graft loss after a kidney transplant due to recurrent HUS.
- Dialysis posed significant risks including access failure and bacteremia.
Findings:
- Genetic analysis revealed compound heterozygous mutations in the complement factor H gene (c.2918G > A, Cys973Tyr and c.3590T > C, Val1197Ala).
- A combined liver-kidney transplant with pre-operative plasma exchange resulted in excellent graft function maintained for over two years.
Implications:
- Combined liver-kidney transplantation is a viable therapeutic option for HUS patients with CFH mutations who have experienced graft failure.
- This approach offers a promising long-term solution for managing this complex condition and improving patient survival.
Abstract:
A male child initially presented with atypical hemolytic uremic syndrome (HUS) at the age of 4 months and progressed within weeks to end stage renal disease (ESRD). At the age of 2 years he received a live-related kidney transplant from his mother, which, despite initial good function, was lost to recurrent disease after 2 weeks. Complement factor H analysis showed low serum levels and the presence of two mutations on different alleles (c.2918G > A, Cys973Tyr and c.3590T > C, Val1197Ala). His survival on dialysis was at risk because of access failure and recurrent bacteremic episodes. Therefore, at the age of 5 years he received a combined liver-kidney transplant with pre-operative plasma exchange. Initial function of both grafts was excellent and this has been maintained for over 2 years. This report suggests that despite setbacks in previous experience, combined liver-kidney transplantation offers the prospect of a favorable long-term outcome for patients with HUS associated with complement factor H mutations.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

